EMEA-001857-PIP02-20
Key facts
Active substance |
Elafibranor
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0295/2020
|
PIP number |
EMEA-001857-PIP02-20
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of primary biliary cholangitis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Ipsen Pharma
E-mail: elafibranor.enquiries@ipsen.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|